financetom
Business
financetom
/
Business
/
Siemens reports 23% increase in net profit to Rs 392 crore
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Siemens reports 23% increase in net profit to Rs 392 crore
Nov 22, 2022 12:59 PM

Siemens on Tuesday reported a 23 percent rise in its net profit from continuing operations to Rs 392 crore in the September 2022 quarter, mainly on the back of higher revenues.

”(In July-September quarter) Profit after Tax (net profit) from continuing operations of Rs 392 crore, increased by 23 per cent over the same period last year,” a company statement said.

The company follows the October-to-September financial year.

For the fourth quarter of Financial Year 2022 ended September 30, Siemens Ltd registered revenue from continuing operations of Rs 4,237 crore, an 11 percent increase over the same quarter in the preceding year, it stated.

New Orders from continuing operations stood at Rs 4,009 crore, registering a 25 per cent increase over the same period last year. The company’s order backlog from continuing operations is Rs 17,183 crore, it noted.

For the Financial Year 2022, Siemens reported an increase of 43 percent in new orders, 18 percent in revenue and 20 percent in profit after tax from continuing operations over the previous financial year, it stated.

Sunil Mathur, Managing Director and Chief Executive Officer, Siemens Limited, said, ”The company’s strong performance showed the resilience of all our businesses, which performed remarkably well. We continue to see an increased pace of tendering for Capex by both public and private sectors with increasing interest in digital and sustainability solutions.”

The board in its meeting also approved a dividend of Rs 10 per equity share of Rs two each (500 percent) for the financial year ended September 30, 2022.

Also read: Vedanta board approves interim dividend of Rs 17.5

The dividend, as recommended by the Board of Directors, if declared at the ensuing annual general meeting (AGM) of the company, would be paid from Friday, February 17, 2023.

The Board of Directors, based on the recommendation of the Nomination and Remuneration Committee, recommended the appointment of Deepak S Parekh as a Director (Non-Executive Non-Independent; liable to retire by rotation) with effect from January 30, 2023, to the members for their approval.

Parekh’s second term as an Independent Director of the company is up to January 29, 2023.

The board also noted that Johannes Apitzsch has tendered his resignation as Director of the company with effect from January 1, 2023, due to other commitments.

Also read: The IPO lock-in period of these five companies ends this week

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Ballard and NYSE's Vertiv Detail Strategic Technology Partnership to Support Alternative Energy Usage for Data Centers
Ballard and NYSE's Vertiv Detail Strategic Technology Partnership to Support Alternative Energy Usage for Data Centers
Jun 18, 2024
08:56 AM EDT, 06/18/2024 (MT Newswires) -- Ballard Power Systems ( BLDP ) and Vertiv , a global provider of digital infrastructure and continuity solutions, on Tuesday sealed a strategic technology partnership with a focus on backup power applications for data centres and critical infrastructures, scalable from 200kW to multiple MWs. In collaborating to demonstrate the technical feasibility and customer...
Intra-Cellular Therapies Says Depressive Disorder Therapy Meets Primary, Secondary Endpoints in Second Late-Stage Study
Intra-Cellular Therapies Says Depressive Disorder Therapy Meets Primary, Secondary Endpoints in Second Late-Stage Study
Jun 18, 2024
08:53 AM EDT, 06/18/2024 (MT Newswires) -- Intra-Cellular Therapies ( ITCI ) said Tuesday that its investigational adjunctive therapy, lumateperone, for treating patients with major depressive disorder, met both the primary and key secondary endpoints in the second late-stage study. The study showed that the therapy resulted in a statistically significant and clinically meaningful reduction in the overall score of...
Grifols Sells 20% Stake in Shanghai RAAS to Haier Group for $1.72 Billion
Grifols Sells 20% Stake in Shanghai RAAS to Haier Group for $1.72 Billion
Jun 18, 2024
08:58 AM EDT, 06/18/2024 (MT Newswires) -- Grifols ( GRFS ) said Tuesday it has sold a 20% stake in blood products company Shanghai RAAS to Haier Group for 12.50 billion Chinese renminbi ($1.72 billion) through a repurchase deal, retaining a 6.58% stake and a board seat. The plasma-derived medicines manufacturer said the two companies have also extended their albumin...
Cedar Fair, Six Flags Say Merger Set for July 1 Completion
Cedar Fair, Six Flags Say Merger Set for July 1 Completion
Jun 18, 2024
08:46 AM EDT, 06/18/2024 (MT Newswires) -- Cedar Fair ( FUN ) and Six Flags Entertainment ( SIX ) said Tuesday they expect their merger to be completed on July 1, pending regulatory approvals and other conditions. The entertainment facilities operating companies said the planned leadership team of the merged company includes Cedar Chief Executive Richard Zimmerman as president and...
Copyright 2023-2026 - www.financetom.com All Rights Reserved